Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Protection and Affordable Care Act | 14 | 2024 | 1186 | 3.460 |
Why?
|
Medicare Part D | 12 | 2024 | 354 | 2.630 |
Why?
|
Medicaid | 12 | 2024 | 2813 | 2.070 |
Why?
|
Cost Sharing | 11 | 2023 | 409 | 1.880 |
Why?
|
Medicare | 14 | 2023 | 6773 | 1.340 |
Why?
|
Insurance Coverage | 14 | 2023 | 1935 | 1.310 |
Why?
|
Mental Health Services | 6 | 2024 | 1716 | 1.180 |
Why?
|
Health Services Accessibility | 10 | 2024 | 5425 | 1.010 |
Why?
|
Prescription Drugs | 3 | 2024 | 631 | 0.940 |
Why?
|
Patient Acceptance of Health Care | 8 | 2024 | 3200 | 0.920 |
Why?
|
Insurance, Health | 12 | 2023 | 2493 | 0.910 |
Why?
|
California | 13 | 2023 | 1431 | 0.880 |
Why?
|
Medically Uninsured | 5 | 2022 | 834 | 0.810 |
Why?
|
Fitness Centers | 1 | 2022 | 13 | 0.810 |
Why?
|
Financing, Personal | 6 | 2020 | 308 | 0.800 |
Why?
|
Community Health Centers | 4 | 2021 | 461 | 0.790 |
Why?
|
United States | 54 | 2024 | 72339 | 0.770 |
Why?
|
Deductibles and Coinsurance | 4 | 2020 | 316 | 0.750 |
Why?
|
Insurance Benefits | 4 | 2024 | 186 | 0.740 |
Why?
|
Health Expenditures | 5 | 2018 | 2362 | 0.740 |
Why?
|
Medicare Part C | 2 | 2024 | 330 | 0.740 |
Why?
|
Taxes | 2 | 2022 | 221 | 0.710 |
Why?
|
Insurance Selection Bias | 2 | 2018 | 69 | 0.690 |
Why?
|
Nurse Practitioners | 1 | 2022 | 269 | 0.640 |
Why?
|
Bipolar Disorder | 6 | 2024 | 5092 | 0.630 |
Why?
|
Fees and Charges | 1 | 2019 | 192 | 0.610 |
Why?
|
Drugs, Generic | 2 | 2016 | 448 | 0.570 |
Why?
|
National Health Programs | 1 | 2020 | 440 | 0.560 |
Why?
|
Poverty | 6 | 2024 | 2691 | 0.550 |
Why?
|
Polypharmacy | 1 | 2019 | 307 | 0.540 |
Why?
|
Antipsychotic Agents | 4 | 2024 | 3064 | 0.540 |
Why?
|
Gender Identity | 1 | 2022 | 766 | 0.520 |
Why?
|
Health Facilities | 1 | 2020 | 575 | 0.510 |
Why?
|
Vaccines | 1 | 2024 | 835 | 0.500 |
Why?
|
Anti-Asthmatic Agents | 5 | 2017 | 573 | 0.500 |
Why?
|
Mental Disorders | 3 | 2024 | 6823 | 0.490 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 619 | 0.470 |
Why?
|
Massachusetts | 10 | 2024 | 8837 | 0.470 |
Why?
|
Patient Compliance | 3 | 2018 | 2688 | 0.460 |
Why?
|
Electronic Mail | 1 | 2015 | 213 | 0.450 |
Why?
|
Medication Adherence | 4 | 2019 | 2175 | 0.440 |
Why?
|
Asthma | 9 | 2017 | 6230 | 0.440 |
Why?
|
Group Homes | 2 | 2024 | 59 | 0.440 |
Why?
|
Risperidone | 1 | 2016 | 381 | 0.440 |
Why?
|
Income | 5 | 2020 | 1869 | 0.430 |
Why?
|
Psychiatry | 2 | 2022 | 1699 | 0.420 |
Why?
|
Influenza, Human | 1 | 2024 | 1521 | 0.410 |
Why?
|
Mental Health | 3 | 2023 | 3251 | 0.400 |
Why?
|
Models, Economic | 1 | 2015 | 714 | 0.380 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 124 | 0.380 |
Why?
|
Adrenal Cortex Hormones | 5 | 2016 | 1878 | 0.360 |
Why?
|
Drug Costs | 5 | 2013 | 1183 | 0.350 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 66 | 0.340 |
Why?
|
Humans | 83 | 2024 | 761208 | 0.340 |
Why?
|
Medically Underserved Area | 2 | 2022 | 254 | 0.320 |
Why?
|
Male | 55 | 2024 | 360693 | 0.320 |
Why?
|
Child Health Services | 1 | 2014 | 644 | 0.310 |
Why?
|
Female | 56 | 2024 | 392544 | 0.300 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2723 | 0.300 |
Why?
|
Primary Health Care | 4 | 2021 | 4678 | 0.300 |
Why?
|
Schizophrenia | 3 | 2022 | 6930 | 0.280 |
Why?
|
Aged | 30 | 2024 | 169288 | 0.270 |
Why?
|
Office Visits | 4 | 2017 | 593 | 0.270 |
Why?
|
Tobacco Smoke Pollution | 2 | 2023 | 821 | 0.270 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4413 | 0.260 |
Why?
|
Minority Groups | 2 | 2024 | 1201 | 0.260 |
Why?
|
Smoking Cessation | 3 | 2022 | 2056 | 0.250 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 709 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3245 | 0.250 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1401 | 0.250 |
Why?
|
Adrenergic beta-Agonists | 3 | 2016 | 346 | 0.240 |
Why?
|
Adult | 33 | 2024 | 221119 | 0.230 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 667 | 0.230 |
Why?
|
Cohort Studies | 11 | 2024 | 41496 | 0.220 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 934 | 0.220 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1789 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2164 | 0.210 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4767 | 0.210 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 26071 | 0.200 |
Why?
|
Criminals | 1 | 2023 | 62 | 0.200 |
Why?
|
Atherosclerosis | 1 | 2018 | 3406 | 0.190 |
Why?
|
Lithium | 2 | 2022 | 596 | 0.190 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 94 | 0.190 |
Why?
|
Young Adult | 12 | 2024 | 59221 | 0.180 |
Why?
|
Housing | 3 | 2023 | 669 | 0.180 |
Why?
|
Food Supply | 2 | 2024 | 539 | 0.180 |
Why?
|
Middle Aged | 24 | 2024 | 220853 | 0.180 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8003 | 0.170 |
Why?
|
Adolescent | 16 | 2024 | 88298 | 0.170 |
Why?
|
Health Benefit Plans, Employee | 3 | 2012 | 332 | 0.170 |
Why?
|
Immunization | 1 | 2024 | 1218 | 0.170 |
Why?
|
Insurance, Medigap | 2 | 2009 | 20 | 0.160 |
Why?
|
Eligibility Determination | 1 | 2022 | 420 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 546 | 0.150 |
Why?
|
Risk Adjustment | 3 | 2011 | 601 | 0.150 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3220 | 0.150 |
Why?
|
Conversion Disorder | 1 | 2021 | 202 | 0.140 |
Why?
|
Clinical Competence | 2 | 2010 | 4788 | 0.140 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5842 | 0.140 |
Why?
|
Tobacco Use Disorder | 1 | 2022 | 703 | 0.140 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1664 | 0.140 |
Why?
|
Emergency Service, Hospital | 6 | 2024 | 7865 | 0.130 |
Why?
|
State Health Plans | 1 | 2018 | 219 | 0.130 |
Why?
|
Fee-for-Service Plans | 1 | 2021 | 698 | 0.130 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 139 | 0.130 |
Why?
|
Nursing Homes | 1 | 2023 | 1083 | 0.130 |
Why?
|
Albuterol | 1 | 2016 | 211 | 0.130 |
Why?
|
Socioeconomic Factors | 5 | 2018 | 7804 | 0.120 |
Why?
|
Developmental Disabilities | 1 | 2024 | 1510 | 0.120 |
Why?
|
Logistic Models | 7 | 2024 | 13249 | 0.120 |
Why?
|
Physicians, Family | 1 | 2017 | 348 | 0.120 |
Why?
|
Hypertension | 3 | 2022 | 8536 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 706 | 0.120 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 348 | 0.120 |
Why?
|
Professional Practice | 1 | 2016 | 313 | 0.110 |
Why?
|
Hospitalization | 5 | 2024 | 10707 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2009 | 937 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2015 | 1159 | 0.110 |
Why?
|
Parents | 3 | 2017 | 3564 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 63 | 0.110 |
Why?
|
Pandemics | 2 | 2023 | 8663 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2680 | 0.100 |
Why?
|
Drug Labeling | 1 | 2015 | 248 | 0.100 |
Why?
|
Data Collection | 1 | 2022 | 3320 | 0.100 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 34 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2012 | 4014 | 0.100 |
Why?
|
Telephone | 1 | 2015 | 624 | 0.100 |
Why?
|
Interviews as Topic | 4 | 2013 | 2697 | 0.100 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 72 | 0.100 |
Why?
|
Sexual Behavior | 1 | 2022 | 2189 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1910 | 0.100 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1668 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2893 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3369 | 0.100 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 26 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1807 | 0.100 |
Why?
|
Public Housing | 2 | 2023 | 140 | 0.090 |
Why?
|
Blood Pressure | 1 | 2007 | 8479 | 0.090 |
Why?
|
Child | 11 | 2023 | 80152 | 0.090 |
Why?
|
Health Planning | 1 | 2012 | 231 | 0.090 |
Why?
|
Hyperlipidemias | 2 | 2013 | 771 | 0.090 |
Why?
|
Drug Utilization | 2 | 2008 | 1188 | 0.090 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1402 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1663 | 0.090 |
Why?
|
Workload | 1 | 2016 | 845 | 0.090 |
Why?
|
Child, Preschool | 9 | 2021 | 42224 | 0.090 |
Why?
|
Diet | 3 | 2024 | 8048 | 0.080 |
Why?
|
Health Policy | 2 | 2022 | 2679 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2013 | 58952 | 0.080 |
Why?
|
Documentation | 1 | 2016 | 900 | 0.080 |
Why?
|
Quality of Health Care | 1 | 2024 | 4320 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1250 | 0.080 |
Why?
|
Telemedicine | 1 | 2006 | 3051 | 0.080 |
Why?
|
Health Care Costs | 4 | 2021 | 3239 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2012 | 567 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3727 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2928 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 26 | 0.070 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1847 | 0.070 |
Why?
|
Mammography | 2 | 2016 | 2430 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3354 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10516 | 0.070 |
Why?
|
Choice Behavior | 1 | 2012 | 825 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.060 |
Why?
|
Health Maintenance Organizations | 3 | 2016 | 658 | 0.060 |
Why?
|
Personal Health Services | 1 | 2005 | 24 | 0.060 |
Why?
|
Health Status | 2 | 2015 | 4077 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1247 | 0.060 |
Why?
|
Information Services | 1 | 2006 | 236 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6304 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 141 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1693 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 3253 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 195 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 611 | 0.060 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 179 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2012 | 940 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10218 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14610 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 442 | 0.050 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3453 | 0.050 |
Why?
|
Bulimia | 1 | 2024 | 400 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2019 | 64681 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3198 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12052 | 0.050 |
Why?
|
Sex Distribution | 1 | 2006 | 2277 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 80674 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2022 | 6011 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9319 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2871 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12159 | 0.040 |
Why?
|
Odds Ratio | 2 | 2013 | 9652 | 0.040 |
Why?
|
Communication | 3 | 2010 | 3872 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 443 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 74239 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6223 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1936 | 0.040 |
Why?
|
Policy | 1 | 2022 | 506 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 520 | 0.040 |
Why?
|
Soil | 1 | 2016 | 116 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5885 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2017 | 153 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5493 | 0.030 |
Why?
|
Depression | 1 | 2015 | 8132 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20119 | 0.030 |
Why?
|
Psychotherapy | 1 | 2024 | 1646 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1224 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2021 | 2770 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1723 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2012 | 2425 | 0.030 |
Why?
|
Databases, Factual | 2 | 2024 | 7966 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2016 | 741 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2015 | 26199 | 0.020 |
Why?
|
Economic Recession | 1 | 2012 | 79 | 0.020 |
Why?
|
Unemployment | 1 | 2012 | 210 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3024 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2012 | 215 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12474 | 0.020 |
Why?
|
Infant | 2 | 2015 | 36169 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2545 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.020 |
Why?
|
Financing, Government | 1 | 2012 | 472 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 565 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 385 | 0.020 |
Why?
|
New York City | 1 | 2010 | 730 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1662 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1916 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9055 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5333 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4015 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2006 | 504 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5426 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2011 | 2359 | 0.010 |
Why?
|
Educational Status | 1 | 2012 | 2510 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2374 | 0.010 |
Why?
|
Computers | 1 | 2005 | 591 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3337 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9616 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15841 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 609 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15721 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5869 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2220 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6345 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13511 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2019 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5295 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22174 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3089 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 14025 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20982 | 0.000 |
Why?
|